Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Artificial intelligence in embryo selection: a reality thanks to IVIRMA Global


VALENCIA, Spain, July 6, 2020 /PRNewswire/ -- As spectacular and futuristic as it may seem, using Artificial Intelligence to automatically analyze embryos in a standardized way to improve pregnancy rates is already a reality. This is confirmed by an IVIRMA Global study entitled 'A universal algorithm is available in last generation time-lapse incubators: embryo score provided by the KIDScoreD5 is strongly correlated with chromosomal status and clinical outcomes'.

IVIRMA Global has already participated in the development of the EmbryoScope (incubator with time-lapse technology) from its beginnings, helping in its evolution and laying the foundations for automatic embryo selection. In its latest development, EmbryoScope presents its newest software system, KIDScoreD5, which automatically performs embryo selection and classification.

The study has been carried out over the last three years and has become the most extensive case study in the history of embryology to date (more than 20,000 embryos and more than 3,000 patients have been analyzed). In the study, IVIRMA Global has demonstrated that universal, standardized and automatic embryo selection is a reality for the field of embryology. As the study's principal researcher, Dr. Marcos Meseguer, scientific supervisor of IVI Valencia, comments, "The KIDScoreD5 system automatically classifies embryos using Artificial Intelligence, it detects and evaluates all the steps in the development of the embryo and also classifies its morphology".

Dr. Meseguer points out that, "We have seen that the KIDScoreD5 system makes an assessment to distinguish between those embryos that are more likely to be chromosomally normal, called euploid embryos, and those that are not, called aneuploid embryos." Based on the score the system gives each embryo, we know its probability of gestation and the possibility of taking a healthy baby home.

The KIDScoreD5 system analyzes the embryos automatically classifying them from one to ten depending on their quality and morphology. Since automated embryo selection is more accurate than manual selection, the probability of a successful pregnancy is directly linked to the percentage score and, therefore, the patient has a greater chance of success.

Main values of the study and the KIDScoreD5 system

About IVIRMA Global

IVI was founded in 1990, as the first medical institution in Spain fully dedicated to assisted reproduction. Since then it has helped with the birth of more than 200,000 babies thanks to the application of the latest technologies. In early 2017, IVI merged with RMANJ, becoming the largest assisted reproduction group in the world. It currently has more than 65 clinics in 9 countries and is the leading centre for reproductive medicine. www.ivi.es - www.rmanetwork.com.

For more information:

IVI



Marián Garriga

[email protected]


Ricardo Pedrós

[email protected]





Equipo Singular



Victor Cámara

[email protected]


Iciar Picardo

[email protected]


 

SOURCE IVIRMA Global


These press releases may also interest you

at 08:07
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has released a comprehensive contract research organization (CRO) offering tailor-made for sponsors looking to bring diagnostic products...

at 08:05
Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today the enrollment of the first patient in a pilot study collecting patient-generated health data (PGHD) during proton radiotherapy for lung cancer in...

at 08:05
Roivant and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and autoimmune diseases, today announced the successful completion of enrollment in its Phase 2 study evaluating namilumab for...

at 08:05
Revvity, Inc. will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV. Senior Vice President and Chief Financial Officer Max Krakowiak will provide an update on the Company and its...

at 08:05
Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on developing next-generation neuropsychiatric therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has notified the...

at 08:05
Microbion Corporation today announced that the company won the Advanced Wound Care Summit's Innovation Showcase award. The Innovation Showcase was designed to give presenters, who were picked by a selection committee, an opportunity to demonstrate...



News published on and distributed by: